oa SA Pharmaceutical Journal - Vimovo® : fixed-dose naproxen/esomeprazole to treat arthritic symptoms : drug info - new product focus

Volume 80, Issue 9
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Vimovo® tablets contain 500 mg naproxen and 20 mg esomeprazole. The product is indicated for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in patients needing proton-pump inhibitors (PPIs) to reduce the risk of developing nonsteroidal anti-inflammatory drug (NSAID)-associated gastric and/or duodenal ulcers.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error